Table 2.
All-Cause Mortality (n = 3366) |
CVD Mortality (n = 674) |
|||
---|---|---|---|---|
Models | HR (95% CI) | P-Value* | HR (95% CI) | P-Value* |
| ||||
Unadjusted | ||||
Glucosamine/chondroitin | ||||
User | 0.88 (0.70 to 1.11) | .27 | 0.51 (0.28 to 0.92) | .03† |
Non-user | — | — | ||
Age adjusted | ||||
Glucosamine/chondroitin | ||||
User | 0.61 (0.49 to 0.77) | <.0001§ | 0.35 (0.20 to 0.61) | .0004§ |
Non-user | — | — | ||
Age, years | ||||
40 to 49 | — | — | ||
50 to 59 | 1.96 (1.55 to 2.48) | <.0001§ | 1.80 (1.02 to 3.15) | .04† |
60 to 69 | 4.38 (3.73 to 5.15) | <.0001§ | 4.98 (2.98 to 8.32) | <.0001§ |
70+ | 15.29 (13.18 to 17.74) | <.0001§ | 17.55 (11.54 to 26.69) | <.0001§ |
Multivariable adjusted | ||||
Glucosamine/chondroitin | ||||
User | 0.73 (0.57 to 0.93) | .01† | 0.42 (0.23 to 0.75) | .004‡ |
Non-user | — | — | ||
Age, years | ||||
40 to 49 | — | — | ||
50 to 59 | 2.01 (1.60 to 2.53) | <.0001§ | 1.90 (1.12 to 3.24) | .02† |
60 to 69 | 4.71 (4.03 to 5.50) | <.0001§ | 5.49 (3.37 to 8.96) | <.0001§ |
70+ | 17.53 (15.18 to 20.25) | <.0001§ | 20.57 (13.97 to 30.29) | <.0001§ |
Sex | ||||
Male | — | — | ||
Female | 0.69 (0.63 to 0.75) | <.0001§ | 0.51 (0.42 to 0.60) | <.0001§ |
Race | ||||
Non-Hispanic White | — | — | ||
Non-Hispanic Black | 1.15 (1.03 to 1.29) | .01† | 1.27 (1.0 to 1.60) | .04† |
Hispanic | 0.87 (0.74 to 1.02) | .08 | 0.88 (0.60 to 1.28) | .49 |
Other | 0.84 (0.62 to 1.12) | .23 | 0.94 (0.43 to 2.04) | .87 |
Education | ||||
≥High school | — | — | ||
<High school | 1.30 (1.17 to 1.45) | <.0001§ | .007‡ | |
Smoking status | ||||
Current smoker | 1.98 (1.78 to 2.20) | <.0001§ | 1.61 (1.23 to 2.10) | .0007§ |
Non-smoker | — | — | ||
Physical activity | ||||
≥150 minutes/week | 0.64 (0.59 to 0.70) | <.0001§ | 0.58 (0.46 to 0.73) | <.0001§ |
<150 minutes/week | — | — |
CVD, cardiovascular disease; HR, hazard ratio; CI, confidence interval.
P-value was estimated from Cox proportional hazards models.
P < .05
P < .01
P < .001.